Trials / Recruiting
RecruitingNCT06421077
Transcutaneous Auricular Vagus Nerve Stimulation Prevents Postoperative Delirium in Elderly Patients
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Prevents Postoperative Delirium in Elderly Patients: a Randomized Controlled Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,776 (estimated)
- Sponsor
- Beijing Tiantan Hospital · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
According to the 3D-CAM scale, evaluate the incidence of Postoperative Delirium within 5 days after surgery in elderly patients receiving taVNS.The results are expected to provide evidence of the safety and efficacy of perioperative prophylactic use of taVNS in the clinical application of improving postoperative brain health in elderly patients, as well as theoretical and practical basis for subsequent studies or clinical applications.
Detailed description
This study aims to conduct a prospective, randomized controlled clinical trial on the preventive use of taVNS to improve the incidence of Postoperative Delirium(POD) in elderly patients undergoing anesthesia surgery. The intervention group will receive "standard-stimulation parameters" of taVNS(25HZ,250μs), while the control group will receive "low-stimulation parameters" of taVNS(1HZ,250μs). The main outcome measure of the study was the incidence of POD within 5 days after surgery. Secondary outcome measures include incidence of new mild and severe postoperative neurocognitive impairment during hospitalization and 90 days, all-cause mortality rate at 90 days, incidence of related adverse events, and length of stay.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | transauricular auricular vagus nerve stimulation | transauricular auricular vagus nerve stimulation |
Timeline
- Start date
- 2024-06-20
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2024-05-20
- Last updated
- 2025-04-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06421077. Inclusion in this directory is not an endorsement.